The strategic collaboration leverages YUN’s proprietary Probiotherapy technology, which incorporates live probiotics into topical formulations to support the skin’s natural ecosystem. Building on initial success in Poland—where the portfolio grew to include both acne and eczema solutions—the companies have now launched these products in the Czech Republic, Slovakia, Ukraine, and Bulgaria. A scheduled rollout in Kazakhstan is set for October 2026.

Cees Heiman, senior vice president for Europe and Canada at Bausch Health, noted that the EMEA region remains a primary focus for the company’s specialized dermatology offerings. Meanwhile, Fernando Zarate, vice president for Latin America, framed the entry into Mexico as a response to evolving consumer preferences for science-led, dermatological care. YUN founder and CEO Tom Verlinden stated that the partnership allows the biotech firm to scale its mission through a partner with established regional reach and clinical credibility.